“Regenerative medicine investigators at the Cedars-Sinai Medical Center have received U.S. Food and Drug Administration (FDA) approval to test a novel combination stem cell-gene therapy they’ve developed to stall amyotrophic lateral sclerosis (ALS) progression. Enrollment in the trial is expected to commence soon.
Also known as Lou Gehrig’s disease, ALS is a neurological disorder that attacks muscle-controlling nerve cells motor neurons in the brain, brainstem and spinal cord, causing progressive paralysis.”
[…]
Read more here.
FDA approves test of combined stem cell and gene therapy for ALS